Isomorphic Labs Completes $5.0 Billion Series C Financing to Advance AI-Driven Drug Design
Isomorphic Labs has completed a $5 billion Series C financing round to advance AI-driven drug design. The round was co-led by Greenoaks and Sequoia Capital, with Alphabet participating once again. The fresh capital will be used to advance its first wave of therapeutic programs into clinical trials.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
The VIX volatility index rose 25.6% from its previous close, currently trading at 24.240.
-
2
Silver prices retreated to $47.013, touching a nearly 365-day low.
-
3
Palantir closed 5.05% lower, currently trading at $159.500.
-
4
WTI crude oil fell 3.9% from its previous close, currently trading at $85.492.
-
5
Silver is down 4.06% from its previous close, currently trading at $46.917.
-
6
AMD is down 6.03% from its previous close, currently trading at $501.865.
-
7
Gold prices pulled back to $3,852.89, hitting a nearly 365-day low.
-
8
HYPE (Hyperliquid) surged 6.35% in 4 hours, currently trading at $70.630
-
9
CNN: U.S. intelligence warns Iran may plot dirty bomb or chemical attack in Washington
-
10
BNB Market Monitoring Tools and Investor Intelligence
Markets Today
Recommended Reading



